Table 1 Baseline characteristics by intervention group

From: Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation

 

DA (n=184)

Control (n=184)

DA_b (n=47)

DA_a (n=42)

Sociodemographic background

 Age: mean (s.d.)

43.7 (11.3)

43.5 (10.4)

38.7 (10.0)

40.3 (9.9)

 Currently married/partner (%)

84

85

85

86

 College or higher (%)

37

32

30

43

 Employed (%)

65

65

70

69

 Have children (%)

80

83

75

69

 Want (more) children (%)

17

15

22

28

 Being religiously affiliated (%)

57 *

71*

52 †

74†

Personal medical history

 No cancer (%)

46

49

70

76

 Breast cancer only (%)

49

46

30

24

 Ovarian cancer only (%)

4

4

0

0

 Breast and ovarian cancer (%)

1

1

0

0

Family medical history

 Breast cancer only (%)

47

54

27

20

 Ovarian cancer only (%)

3

3

0

3

 Breast and ovarian cancer (%)

50

43

73

77

 Known familial mutation (%)

47

44

77

76

 First-degree relatives with bc or oc (%)

66

69

71

77

 First-degree relatives died of bc or oc (%)

28

27

34

31

Well-being

 Anxiety: mean (s.d.)

40.9 (11.4)*

38.6 (10.7)*

40.1 (10.6)

37.4 (11.5)

 Depression: mean (s.d.)

9.3 (8.6)

8.4 (8.1)

7.5 (7.1)

8.6 (8.6)

 Cancer related distress: mean (s.d.)

20.1 (14.8)

18.1 (13.5)

18.5 (13.8)

17.1 (12.9)

 General health: mean (s.d.)

7.3 (1.7)*

7.6 (1.4)*

7.9 (1.4)

8.0 (1.5)

  1. bc: breast cancer; oc: ovarian cancer.
  2. *P<0.10 comparing the DA and control groups.
  3. †P<0.10 comparing the DA_b and DA_a groups.